33813-75-1

Basic information

• Product Name: (1R,3aR,7aR)-1-((2R,5S)-5,6-diMethylheptan-2-yl)-7a-Methyloctahydro-1H-inden-4-ol
• Synonyms: (1R,3aR,7aR)-1-((2R,5S)-5,6-diMethylheptan-2-yl)-7a-Methyloctahydro-1H-inden-4-ol;XBGWXALJZVHJOM-PEVAVHCHSA-N
• CAS NO: 33813-75-1
• Molecular Formula: C19H36O
• Molecular Weight: 280.48854
• Mol File: 33813-75-1.mol

Chemical Properties

• Boiling Point: 338.6±10.0 °C(Predicted)
• Appearance: /
• Density: 0.921±0.06 g/cm3(Predicted)
• PKA: 15.07±0.60(Predicted)
• CAS DataBase Reference: (1R,3aR,7aR)-1-((2R,5S)-5,6-diMethylheptan-2-yl)-7a-Methyloctahydro-1H-inden-4-ol(CAS DataBase Reference)
• NIST Chemistry Reference: (1R,3aR,7aR)-1-((2R,5S)-5,6-diMethylheptan-2-yl)-7a-Methyloctahydro-1H-inden-4-ol(33813-75-1)
• EPA Substance Registry System: (1R,3aR,7aR)-1-((2R,5S)-5,6-diMethylheptan-2-yl)-7a-Methyloctahydro-1H-inden-4-ol(33813-75-1)

Safety Data

• Hazardous Substances Data: 33813-75-1(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
(1R,3aR,7aR)-1-((2R,5S)-5,6-dimethylheptan-2-yl)-7a-methyloctahydro-1H-inden-4-ol is used as a key intermediate in organic synthesis for the development of novel compounds with potential applications in various industries.
Used in Pharmacology:
(1R,3aR,7aR)-1-((2R,5S)-5,6-dimethylheptan-2-yl)-7a-methyloctahydro-1H-inden-4-ol is used as a starting material in the design and synthesis of new pharmaceutical agents, leveraging its unique structural features to explore its potential therapeutic properties.
Used in Natural Product Chemistry:
(1R,3aR,7aR)-1-((2R,5S)-5,6-dimethylheptan-2-yl)-7a-methyloctahydro-1H-inden-4-ol is utilized in the study of natural products to understand its role in the essential oils of plants and to investigate its potential biological activities.

Upstream product

• 55812-80-1 (1R,3aR,7aR)-7a-Methyl-1-((E)-(1R,4R)-1,4,5-trimethyl-hex-2-enyl)-octahydro-inden-4-one 
• 50-14-6 Calciferol 
• 55812-82-3 (1R,3aR,4S,7aR)-7a-methyl-1-<(2E)-(1R,4R)-1,4,5-trimethyl-hex-2-enyl>-octahydro-1H-inden-4-ol 
• 131852-63-6 (5Z,22E)-(7R)-3β-(tert-butyldimethylsilyloxy)-9,10-seco-8α-ergosta-5,10(19),22-triene-7,8-diol 
• 84985-78-4 (4R,7aR)-1-((2R,5R,E)-5,6-dimethylhept-3-en-2-yl)-4-((R,Z)-1-hydroxy-2-((S)-5-hydroxy-2-methylenecyclohexylidene)ethyl)-7a-methyloctahydro-1H-inden-4-ol 

Downstream Products

• 245433-13-0 (3R,3aR)-3a-methyl-7-phenylsulfonyl-3-<(1R,4S)-1,4,5-trimethyl-hexyl>-2,3,3a,4,5,6-hexahydro-1H-indene 
• 245433-10-7 (3R,3aR)-3a-methyl-7-phenylsulfanyl-3-<(1R,4S)-1,4,5-trimethyl-hexyl>-2,3,3a,4,5,6-hexahydro-1H-indene 
• 71830-70-1 (1R,3aR,4S,7aR)-4-benzenesulfonyl-7a-methyl-1-<(1R,4S)-1,4,5-trimethyl-hexyl>-octahydroindene 
• 58322-11-5 (1R,3aR,7aR,1'R,4'S)-5,6,7,7a-tetrahydro-7a-methyl-1-(1',4',5'-trimethylhexyl)-3aH-indan-4-one 

Relevant articles and documents

Synthesis of two osteoclast-forming suppressors, demethylincisterol A 3 and chaxine A

The synthesis of two potent osteoclast-forming suppressing agents isolated from the Chinese mushroom Agrocybe chaxingu, demethylincisterol A3 and chaxine A, was accomplished using ergocalciferol as the starting material. Our methodology for the synthesis of demethylincisterol A3 and chaxine A featured the construction of a butenolide moiety by the intramolecular Horner-Wadsworth-Emmons reaction under Masamune-Roush conditions. This is the first reported synthesis of chaxine A.

VITAMIN D RECEPTOR ACTIVATORS AND METHODS OF MAKING

The invention relates to compounds that are vitamin D receptor activators, compositions comprising such compounds, methods of using such compounds and compositions, processes for preparing such compounds, and intermediates obtained during such processes.

On the Julia Alkenylation reaction in vitamin D synthesis. Isolation of four geometrical isomers of vitamin D4

Coupling of sulfone 2 and aldehyde 3b using the Julia alkenylation procedure has been reexamined using modern product separation techniques. It was found that vitamin D4 1b and its geometric isomers 10, 11 and 12 are formed in a ratio of 75:10:10:5, respectively. The building blocks 2 and 3b were prepared from vitamin D2. Correlations for the structure assignment of vitamin D stereoisomers by 1H NMR spectroscopy are presented.